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During a follow-up period of 3 years, among a con- 
secutive series of 423 patients who gave informed 
consent for recatheterization both 1 and 3 years 
after coronary artery bypass grafting, the incidence 
of severely symptomatic patients with New York 
Heart Association class Ill or IV was 19% (79 of 
423). The predictive value of approximately 80 
clinical, angiographic and perioperative variables 
was too low to be of clinical value. Adverse clinical 
outcome was associated with a high closure rate of 
the grafts. Forty-six percent of the patients could not 
undergo reoperation because of unsuitable coronary 
anatomy. With intensive medical therapy half of 
these patients improved to functional class I or II, 
while of those patients who were reoperable 32 % 
improved to class I or II with intensive pharmaco- 
logic treatment instead of reoperation. The nonre- 
sponders underwent reoperation, which resulted in 
improvement of symptoms to functional class I or II 
in most (83 % ). (Am J Cardiol 1985;55:362-366) 
In this report we focus on patients who became severely 
symptomatic after coronary artery bypass grafting 
(CABG) during 3 years of follow-up. The following 
questions were posed: What is their incidence? Can an 
adverse postoperative outcome be predicted from pre- 
operative or perioperative variables? What are the ex- 
planatory factors for this adverse outcome? What is the 
reoperability rate, how were these patients actually 
managed and what was their clinical outcome? 
Methods 
From January 1976 to December 1979, a consecutive series 
of 637 patients underwent CABG at the Thoraxcenter, Rot- 
terdam. All patients had symptoms before operation despite 
adequate medical treatment. The complaints were stable or 
unstable angina. Patients with coexisting valvular or con- 
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genital heart disease, those who had undergone left ventricular 
(LV) aneurysmectomy, surgery for dysrhythmias, and those 
with a life expectancy of less than 5 years because of other 
serious disease were excluded. Four hundred twenty-three 
patients (66%) agreed to undergo recatheterization at 1 and 
3 years after operation, irrespective of their postoperative 
complaints. These patients constitute the study population. 
Before CABG, 34% of the patients did not agree to undergo 
2 postoperative catheterizations. On the basis of clinical data 
(age, sex, severity of symptoms and previous myocardial in- 
farction [MI]) and preoperative angiographic data (severity 
and extent of coronary artery disease (CAD) and LV function), 
both groups (no informed consent vs informed consent) were 
comparable. 
Of the 423 patients who formed the study population, 3 died 
during operation. During a follow-up of 3 years, 79 patients 
have become severely symptomatic and 341 patients have had 
no or mild symptoms. (Fig. 1). 
Follow-up and management: All patients were seen every 
6 months in the outpatient department over the 3-year period. 
Severe symptoms (persistent or recurrent) were defined as 
angina pectoris of New York Heart Association (NYHA) 
functional class III or IV severity. All but 1 of the 79 severely 
symptomatic patients could be evaluated with angiography. 
Reoperability was assessed in joint discussion between the 
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cardiac surgeons and cardiologists. After assessment of re- 
operability, all severely symptomatic patients were initially 
treated with intense pharmacologic therapy. The patients who 
had no adequate response to this treatment and those who 
desired a reoperation (a minority) underwent reoperation. 
Intensive pharmacologic therapy consisted of nitrates (short- 
and long-acting) and P-adrenergic agents, inasmuch as cal- 
cium antagonists were not available before 1979. 
Of the 341 patients with no or mild symptoms despite initial 
agreement for recatheterization, 276 actually underwent this 
procedure at 1 year and 158 at 3 years. The patients who did 
not undergo recatheterization refused upon reconsideration. 
Clinically available information indicated that the patients 
who refused recatheterization did not differ from those who 
consented. 
Coronary angiography: Selective coronary angiography 
was performed in multiple projections including hemiaxial 
views. The degree of luminal narrowing was coded according 
to the guidelines of the American Heart Association.1 The 
degree of luminal narrowing was assessed visually and scored 
as less than 50%, 50 to 89%, 90 to 99%, and 100%. The bypass 
grafts were infused selectively with contrast medium to es- 
tablish patency. 
The severity of the underlying CAD before and after CABG 
was quantified by the coronary score system developed by 
Leaman and Brower and their co-workers.sJ This coronary 
score represents the combined effect of the disease in a seg- 
ment of the coronary artery weighted according to the sig- 
nificance of that vessel. A score of 0 would indicate no ob- 
structive disease, whereas the higher the score, the greater the 
severity of disease. 
In deriving the postoperative coronary score, a vessel seg- 
ment supplied by a graft was considered to take over the dis- 
ease factor, if any, of the graft, provided there was no other 
total occlusion distal to this segment and proximal to the graft 
anastomose. This postoperative score represents remaining 
CAD, taking into account disease in the native system as well 
as closure of grafts. 
From this principle, 2 additional postoperative scores could 
be derived: the coronary score corrected for CABG immedi- 
ately after surgery and during follow-up, assuming all grafts 
patent and normal, representing remaining disease in the 
native coronary system that could not be effectively bypassed, 
and the coronary score corrected for CABG assuming all grafts 
closed (or not placed), representing severity of disease in the 
total native coronary system during follow-up. 
Statistical analysis: Univariate statistical analysis was 
performed using either the chi-square test or Student t test 
when appropriate using double-sided distributions. Multi- 
variate discriminant function stepdown function analysis was 
performed with program P7M of the BMDP statistical 
package. 
Results 
Characteristics of the population: Of the 423 pa- 
tients, 93% were men; mean age was 51.6 f 7.1 years. 
Sixty-eight percent had a previous MI. Sixteen percent 
of the patients had l-vessel, 27% had 2-vessel, 50% had 
3-vessel and 6% left main CAD. Sixty percent of the 
patients had an ejection fraction greater than 0.50,24% 
between 0.30 and 0.50, and 2% less than 0.30; the ejec- 
tion fraction was unknown in 13%. The perioperative 
mortality was 0.7% (3 of 423 patients). During a fol- 
low-up of 3 years the incidence of severely symptomatic 
patients was 19% (79 of 420 patients) (Fig. 1). 
Predictability of postoperative clinical outcome: 
The most important pre- and perioperative clinical and 
angiographic variables are presented in Tables I, II and 
III. Multivariate analysis showed that 3 variables had 
independent predictive value for postoperative severe 
angina: a low preoperative coronary score, performance 
of endarterectomy, and absence of previous MI. To- 
gether, these 3 variables correctly predicted 60% of the 
patients with adverse clinical outcome and 62% of the 
patients with no or mild symptoms. 
Explanatory factors for severe symptoms after 
bypass surgery: The results of pre-, peri- and postop- 
erative angiographic variables are shown in Table IV 
and Figure 2. An adverse clinical outcome is associated 
with a higher corrected coronary score, caused by a 
lower patency rate. There were no differences in pre- 
operative extent of CAD, the number of nonbypassed 
stenoses, or progression of disease in the native coronary 
circulation. 
Reoperability, management and clinical out- 
come: Reoperability was assessed in 70 patients; 46% 
of them were unable to undergo reoperation for tech- 
nical reasons. The actual management and resulting 
clinical outcome are shown in Figure 3. Intensive 
pharmacologic treatment was offered to all patients who 
could not undergo reoperation. 
Discussion 
Many patients suffer from angina pectoris after 
CABG. During a follow-up study of 75 unselected pa- 
tients, Campeau et al4 found a recurrence rate of angina 
pectoris of 38% at 1 year after operation, 45% at 3 years 
and 63% at 7 years. In a follow-up study of 748 patients 
for 5 to 94 months, Cameron et al5 found a recurrence 
rate of angina of 21% at 1 year to 37% at 6 years. The 
severity of angina was generally milder than before 
operation. The European Coronary Surgery StudyG 
reported a postoperative recurrence rate of angina of 
42% at 1 year and 51% at 3 years. In approximately half 
of.the patients the symptoms were unchanged or even 
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FIGURE 1. Incidence of patients with severe symptoms during 3 years 
follow-up after coronary artery bypass surgery (CABG). 
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TABLE I Predictive Value of Clinical Variables 
Severely No or 
Symptomatic Mild 
Patients Symptoms 
(n = 79) (n = 340) 
Variable n (%) n (%) p Value 
Men 
Age >53 yr 
History of MI 
Cigarette smoker 
Cerebrovascular disease 
Diastolic BP > 100 mm Hg 
Diabetes mellitus 
Family history of CAD 
4th heart sound 
CT ratio >0.5 
Total serum cholesterol 
>7.0 mmollliter 
Serum triglycerides 
>2.5 mmol/liter 
;; gj 
21 (27) 
33 (42) 
6 (8) 
i; I:;{ 
40 (51) 
35 (44) 
22 (28) 
316 (93) 
171 (50) 
240 (7 1) 
298: I;:{ 
101 (30) 
17 (5) ’ 
178 (52) 
43 (13) 
167 (49) 
146 (43) 
91 (27) 
p value: univariate analysis, x2 test. 
BP = blood pressure; CAD = coronary artery disease; CT = car- 
diothoracic; Ml = myocardial infarction; NS = not significant. 
TABLE Ill Predictive Value of Perioperative Variables 
Variable 
Severely No or 
Symptomatic Mild 
Patients Symptoms 
(n = 79) (n = 340) 
n (%) n(%) o Value 
Multiple grafts placed 
Lowest flow per graft <45 ml 
Total graft flow X0 ml 64 (81) 
Coronary endarterectomy 39 (49) 
Duration ECC > 110 min. 36 (46) 
Duration ACC >35 min. 37 (47) 
Perioperative infarction 
gz\ IABP assistance 
p value: univariate analysis, x2 test. 
time; ECC = 
ACC = aortic cross-clamping 
extracorporeal circulation: IABP = intraaortic balloon 
pumping; NS = not significant. 
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TABLE II Predictive Value of Preoperative Angiographic 
Variables 
Variable 
Severely 
Symptomatic 
Patients 
(n = 79) 
n (%) 
No or 
Mild 
Symptoms 
(n = 340) 
n (%) p Value 
Pain during APST 
l-;E>;s>ol3 mm Hg 
3-vessh CAD 
Multivessel CAD 
Preoperative 
coronary score > 15 
;;z 1;:; NS 
NS 
38 (48) 139 (41) NS 
ii I::,’ fg”? gi; Ls” 
23 (29) 138 (41) <0.05 
p value: univariate statistics, x2 test. 
APST = atrial pacing stress test; CAD = coronary artery disease; 
EF = ejection fraction; LVEDP = left ventricular end-diastolic pressure; 
NS = not significant. 
worse than before operation. Rahimtoola7 reported that 
CABG reduced symptoms in 76 to 90% of patients; 33 
to 55% became asymptomatic, 5 to 6% showed deterio- 
ration of symptoms after surgery, and angina recurred 
at an annual rate of 2 to 4%. 
Laird-Meeter et al8 studied 1,041 patients with a 
follow-up of 1 to 10 years (mean 3.5). The incidence of 
postoperative angina pectoris at 1 year was 30%, at 3 
years 46% and at 8 years 50%. However, 89% of these 
symptomatic patients felt themselves improved by 
surgery. In this study, approximately 40% of the oper- 
ated patients reported angina pectoris during a fol- 
low-up period of 3 years, which is in agreement with the 
studies cited earlier. Half of these patients had severe 
angina pectoris. Thus the incidence of severe symp- 
tomatic patients with NYHA class III to IV during a 
3-year follow-up was 19%; most of the patients had class 
III symptoms. 
Predictability of clinical outcome after bypass 
surgery: Obviously, patient management could be 
FIGURE 2. Progression of coronary 
artery disease (CAD) in severely symp- 
tomatic patients (A) and asymptomatic 
or mildly symptomatic patients (B). 
CABG = coronary artery bypass graft 
progression CAD of 
not bypassed stenoses 
oreoo u 1 5 
YEARS AFTER SURGERY 
---- native coronary circulation (all wafts occluded) 
- corrected for CABG, actual state of grafts 
-.-a- corrected for CABG, all grafts patent and normal 
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TABLE IV Explanatory Factors for Severe Symptoms After Coronary Artery Bypass Grafting 
Variable 
Severely 
Symptomatic 
(n = 79) 
No or Mild Symptoms 
(n = 340) 
Preoperative 
LV end-diastolic pressure 
Ejection fraction 
Preoperative coronary score 
Perioperative coronary score (all grafts assumed 
own) 
No. of grafts placed 
17fa 
0.59 f 0.11 
11.3 f 7.7 
1.1 f 2.1 
2.3 f 0.8 
Postoperative 
17f6 (NS) 
0.58 f 0.11 (NS) 
14.2 f 7.2 (p <0.05) 
1.8 f 3.0 (NS) 
2.3 f 0.8 (NS) 
No. of recatheterizations 
Follow-up after surgery 
(range, SD) (days) 
Postoperative coronary score 
Native coronary circulation 
Corrected score (grafts in actual state) 
Corrected score (grafts assumed open) 
Patency rate grafts 
Values are mean + standard deviation. 
78 
688 days 
20-1533,425 
17f9 
9.2 f 7.8 
2.7 f 4.3 
55% 
276 
1 year 
271-776,66 
19 f a (NS) 
5.0 f 5.7 (p <O.OOl) 
2.3 f 3.6 (NS) 
82% (p <o.oool) 
162 
3 years 
912-1462, a4 
22 f9 (p <O.Ol) 
6.8 f 7.5 (p <0.05) 
4.1 f 4.9 (NS) 
80% (p <o.oool) 
p value: univariate statistics, unpaired t test, no symptoms vs Symptoms. 
NS = not significant; SD = standard deviation. 
improved if adverse postoperative outcome could be 
predicted. Of the approximately 80 analyzed clinical, 
angiographic and perioperative variables, 3 variables 
were associated with clinical outcome, but classified 
outcome correctly in only 61% of all patients. This 
predictive value is too low to be clinically useful. 
Explanatory factors for severe symptoms after 
bypass surgery: Postoperative angina pectoris is often 
related to incomplete revascularization, early closure 
of grafts or progression of coronary sclerosis in the na- 
tive coronary a.rteries.4!g-13 Adverse clinical outcome was 
associated with a higher attrition rate of grafts, whereas 
no differences were found in the rate of incomplete re- 
vascularization or progession of CAD in the native 
system of patients with no or mild symptoms compared 
with those who had severe symptoms. We do not know 
the reason for this higher graft closure rate in the 
symptomatic patients; although a low intraoperative 
graft flow, performance of endarterectomy and per- 
ioperative complications are associated with a higher 
graft attrition rate, I4 these findings do not imply that 
all these patients became severely symptomatic, as was 
the endpoint in this study. 
Reoperability rate, management and clinical 
outcome of severely symptomatic patients: The 
reoperability rate of severely symptomatic patients was 
about 50%. In the remainder, coronary anatomy was 
unsuitable for further surgery. With intensive medical 
treatment, 50% of these patients improved to NYHA 
class I or II. Most of the reoperable patients were ini- 
tially offered intense medical treatment before repeat 
surgery was advised; with such treatment about one- 
third of the patients improved to class I or II symptoms. 
The others underwent reoperation, after which 83% 
improved to class I, II or III. 
1. 
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